UNSPSC 51434952: Methyclothiazide/pargyline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434952 Methyclothiazide/pargyline is a Commodity code covering specific pharmaceutical active ingredients and formulations that state and local governments procure for emergency medical services, pharmacy benefit programs, and health agency dispensing operations. Recent solicitations show state and local buyers acquiring advanced life support medications, generic multi-source pharmaceuticals, and OTC products through both direct procurement and cooperative purchasing arrangements, with emphasis on FDA-compliant formulations, cGMP certification, and Drug Supply Chain Security Act compliance.

The issuing bodies span city fire rescue departments, state health and human services commissions, and multistate cooperative purchasing alliances. The City of Tampa Fire Rescue issued an IFB (Solicitation 26P00188, due April 8, 2026) for advanced life support medications including labetalol, epinephrine, adenosine, and diltiazem vials, with an estimated contract value of $40,000 and a one-year term with two optional renewals; the contract included a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount. The Texas Health and Human Services Commission issued an RFI (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026 and a two-year initial contract term; evaluation weighted price competitiveness at 75 percent and required vendors to maintain relationships with authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and carry insurance coverage including $5,000,000 commercial general liability per occurrence. Recent activity concentrates in Florida, Texas, and Minnesota.